Liver X receptorβ (LXRβ, also known as NR1H2) is a nuclear receptor, which is considered as the core of modern pharmacology, and the promising therapeutic target for lipid disorders, atherosclerosis, chronic inflammation, autoimmunity, cancer and neurodegenerative diseases1, 2. This evidence concerns the gene NR1H2 and atherosclerosis.